Veterinary and Comparative Oncology This is an RSS file. You can use it to subscribe to this data in your favourite RSS reader or to display this data on your own website or blog.

---
Veterinary and Comparative Oncology, Ahead of Print. (Source: Veterinary and Comparative Oncology)
Source: Veterinary and Comparative Oncology - January 23, 2018 Category: Veterinary Research Source Type: research

Recent advances in veterinary radiation oncology
Veterinary and Comparative Oncology, EarlyView. (Source: Veterinary and Comparative Oncology)
Source: Veterinary and Comparative Oncology - January 14, 2018 Category: Veterinary Research Source Type: research

---
Veterinary and Comparative Oncology, Ahead of Print. (Source: Veterinary and Comparative Oncology)
Source: Veterinary and Comparative Oncology - January 14, 2018 Category: Veterinary Research Source Type: research

Association of tumour ‐infiltrating regulatory T cells with adverse outcomes in dogs with malignant tumours
Veterinary and Comparative Oncology, EarlyView. (Source: Veterinary and Comparative Oncology)
Source: Veterinary and Comparative Oncology - January 11, 2018 Category: Veterinary Research Source Type: research

Clinical characteristics and outcome in dogs with small cell T ‐cell intestinal lymphoma
Veterinary and Comparative Oncology, EarlyView. (Source: Veterinary and Comparative Oncology)
Source: Veterinary and Comparative Oncology - January 11, 2018 Category: Veterinary Research Source Type: research

---
Veterinary and Comparative Oncology, Ahead of Print. (Source: Veterinary and Comparative Oncology)
Source: Veterinary and Comparative Oncology - January 11, 2018 Category: Veterinary Research Source Type: research

Clinical characteristics and outcome in dogs with small cell T ‐cell intestinal lymphoma
The objective of this study was to describe clinical characteristics and outcome in dogs with small cell intestinal lymphoma. We hypothesized that affected dogs would have prolonged survival compared with high‐grade gastrointestinal (GI) lymphoma. Pathology records were searched for dogs with histologically confirmed small cell GI lymphoma. Seventeen dogs with confirmed small cell intestinal lymphoma were identified, and clinical and outcome data were retrospectively collected. Histopathology was reviewed by a board‐certified pathologist, and tissue sections were subjected to immunophenotyping and molecular clonality a...
Source: Veterinary and Comparative Oncology - January 11, 2018 Category: Veterinary Research Authors: K. M. Couto, P. F. Moore, A. L. Zwingenberger, J. L. Willcox, K. A. Skorupski Tags: ORIGINAL ARTICLE Source Type: research

Dosimetric benefit of adaptive radiotherapy in the neoadjuvant management of canine and feline thymoma —An exploratory case series
Veterinary and Comparative Oncology, EarlyView. (Source: Veterinary and Comparative Oncology)
Source: Veterinary and Comparative Oncology - January 8, 2018 Category: Veterinary Research Source Type: research

---
Veterinary and Comparative Oncology, Ahead of Print. (Source: Veterinary and Comparative Oncology)
Source: Veterinary and Comparative Oncology - January 8, 2018 Category: Veterinary Research Source Type: research

In vitro efficacy of a first ‐generation valosin‐containing protein inhibitor (CB‐5083) against canine lymphoma
Veterinary and Comparative Oncology, EarlyView. (Source: Veterinary and Comparative Oncology)
Source: Veterinary and Comparative Oncology - January 4, 2018 Category: Veterinary Research Source Type: research

Biodistribution and tolerance of intravenous iodine ‐131‐labelled hypericin in healthy dogs
Veterinary and Comparative Oncology, EarlyView. (Source: Veterinary and Comparative Oncology)
Source: Veterinary and Comparative Oncology - January 4, 2018 Category: Veterinary Research Source Type: research

---
Veterinary and Comparative Oncology, Ahead of Print. (Source: Veterinary and Comparative Oncology)
Source: Veterinary and Comparative Oncology - January 4, 2018 Category: Veterinary Research Source Type: research

In vitro efficacy of a first ‐generation valosin‐containing protein inhibitor (CB‐5083) against canine lymphoma
Valosin‐containing protein (VCP), through its critical role in the maintenance of protein homeostasis, is a promising target for the treatment of several malignancies, including canine lymphoma. CB‐5083, a first‐in‐class VCP inhibitor, exerts cytotoxicity through the induction of irreversible proteotoxic stress and possesses a broad spectrum of anticancer activity. Here, we determined the cytotoxicity CB‐5083 in canine lymphoma cells and its mechanism of action in vitro. Canine lymphoma cell lines were treated with varying concentrations of CB‐5083 and assessed for viability by trypan blue exclusion and apoptos...
Source: Veterinary and Comparative Oncology - January 4, 2018 Category: Veterinary Research Authors: A. Gareau, C. Rico, D. Boerboom, M. ‐E. Nadeau Tags: ORIGINAL ARTICLE Source Type: research